Are you ready to learn about the latest breakthroughs in digital pathology? Join Deep Bio at booth #3445 and discover how DeepDx® Prostate is empowering pathologists to diagnose and treat prostate cancer with unprecedented accuracy and efficiency.
In addition to showcasing cutting-edge technology, Deep Bio are thrilled to announce that they will be presenting two research abstracts at AACR related to biomarkers in prostate and breast cancers. These abstracts represent the latest in our ongoing efforts to improve cancer diagnosis and treatment through advanced computational pathology.
Make sure to mark your calendar for these important dates:
- Sunday, Apr 16 / 1:30 PM-5:00 PM: Clonal evaluation of ERG/SPINK1 status to determine disease progression using whole mount prostatectomy specimens
- Tuesday, Apr 18 / 1:30 PM-5:00 PM: Predicting protein receptor status from H&E-stained images in breast cancer
Join Deep Bio at AACR and see for yourself how DeepDx® Prostate and our other innovative solutions are transforming the field of digital pathology. Book a meeting or demo today at www.deepbio.co.kr.
